ESC Premium Access

Bridging of antithrombotic therapy for invasive procedure

Event: ESC CONGRESS 2016
Topic: Antithrombotic agents
Session type: Symposium
Date: 29 August 2016
Time: 11:00 - 12:30

Congress Session

4 presentations in this session

Interruption of antiplatelet therapy: benefits and risks

Speaker: Professor J. Collet (Paris, FR)
Thumbnail

Role of intravenous agents

Speaker: Professor J. Morais (Leiria, PT)
Thumbnail

Oral anticoagulation for atrial fibrillation: interruption or bridging?

Speaker: Professor F. Verheugt (Amsterdam, NL)
Thumbnail

Resumption of oral antithrombotics

Speaker: Professor S. Halvorsen (Oslo, NO)
Thumbnail

4 speakers from this session

Professor Jean-Philippe Collet

Sorbonne Universite Pitie Salpetriere Hospital, Paris (France)
17 presentations
0 follower

Professor Joao Morais

Leiria Hospital Centre, Leiria (Portugal)
13 presentations
0 follower

Professor Freek Verheugt

Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
21 presentations
0 follower

Professor Sigrun Halvorsen

Oslo University Hospital Ulleval, Oslo (Norway)
20 presentations
0 follower

This platform is supported by

logo Novo Nordisk